Free Trial

The Clorox Company (NYSE:CLX) Shares Purchased by Quarry LP

Clorox logo with Consumer Staples background

Quarry LP increased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 741.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,961 shares of the company's stock after buying an additional 2,609 shares during the period. Quarry LP's holdings in Clorox were worth $481,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Mendel Capital Management LLC boosted its stake in shares of Clorox by 8.5% during the fourth quarter. Mendel Capital Management LLC now owns 3,539 shares of the company's stock valued at $575,000 after acquiring an additional 278 shares during the last quarter. Susquehanna Fundamental Investments LLC purchased a new stake in shares of Clorox during the fourth quarter worth about $19,089,000. Coldstream Capital Management Inc. raised its position in shares of Clorox by 7.3% in the fourth quarter. Coldstream Capital Management Inc. now owns 3,889 shares of the company's stock valued at $632,000 after buying an additional 263 shares during the last quarter. Integrated Wealth Concepts LLC lifted its stake in shares of Clorox by 46.1% during the fourth quarter. Integrated Wealth Concepts LLC now owns 13,756 shares of the company's stock valued at $2,234,000 after buying an additional 4,341 shares during the period. Finally, Banco Bilbao Vizcaya Argentaria S.A. boosted its position in Clorox by 2.9% during the fourth quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 62,504 shares of the company's stock worth $10,143,000 after acquiring an additional 1,774 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on CLX. JPMorgan Chase & Co. cut their target price on Clorox from $173.00 to $151.00 and set a "neutral" rating on the stock in a research report on Friday, April 11th. Barclays dropped their target price on Clorox from $139.00 to $134.00 and set an "underweight" rating on the stock in a report on Friday, April 11th. DA Davidson lowered their price objective on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Evercore ISI boosted their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, UBS Group reduced their price target on Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a report on Thursday, April 17th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, Clorox currently has a consensus rating of "Hold" and an average price target of $153.83.

Read Our Latest Stock Analysis on CLX

Clorox Stock Performance

Shares of NYSE CLX traded up $0.34 during mid-day trading on Friday, hitting $138.88. The company had a trading volume of 1,206,495 shares, compared to its average volume of 1,290,566. The stock has a market cap of $17.11 billion, a price-to-earnings ratio of 37.95, a PEG ratio of 2.62 and a beta of 0.60. The firm's 50 day simple moving average is $144.14 and its two-hundred day simple moving average is $154.97. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business earned $2.16 earnings per share. As a group, equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.51%. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines